Drug delivery partnerships now available for world’s strongest broad-spectrum antibiotic

(1888PressRelease) Partnerships are now available for new topical that kills all Gram-positive and Gram-negative bacteria pathogens that have been available for testing.

Minneapolis, MN, USA - The availability of drug delivery partnerships was announced this week at the LifeScience Alley Conference & Expo in Minneapolis, MN, on December 8. These partnership opportunities are based on the development of a new drug delivery formulation by Phillips Company, an FDA-registered Native American owned pharmaceutical manufacturer located in Oklahoma.

Read more on Drug delivery partnerships now available for world’s strongest broad-spectrum antibiotic…

Fact Sheet Reveals Mexico’s Increasing Investment In Biopharmaceutical Sector

(1888PressRelease) Global Health Progress highlights benefits of investment, including improving access to medicines and economic growth.

Washington, DC-MD-VA-WV - A recent Global Health Progress fact sheet highlights how Mexico’s investment in its biopharmaceutical sector has spurred economic growth, fostered global competitiveness, reduced the health and economic burden of disease on local citizens, and improved access to medicines. With the tenth largest economy in the world, Mexico is currently investing more than 1% of its gross domestic product into its biopharmaceutical sector and this percentage is anticipated to increase as the country works to develop tomorrow’s medicines.

Read more on Fact Sheet Reveals Mexico’s Increasing Investment In Biopharmaceutical Sector…